Yabao Pharmaceutical Group Co., Ltd (SHA:600351)

SHA:600351 Revenue

Yabao Pharmaceutical Group had revenue of 572.02M CNY in the quarter ending March 31, 2026, a decrease of -6.92%. This brings the company's revenue in the last twelve months to 2.20B, down -13.12% year-over-year. In the year 2025, Yabao Pharmaceutical Group had annual revenue of 2.24B, down -16.60%.

• Revenue (ttm): 2.20B
• Revenue Growth: -13.12%
• P/S Ratio: 2.18
• Revenue / Employee: 608.57K
• Employees: 3,611
• Market Cap: 4.78B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.24B	-445.97M	-16.60%
Dec 31, 2024	2.69B	-223.73M	-7.69%
Dec 31, 2023	2.91B	191.63M	7.05%
Dec 31, 2022	2.72B	-45.83M	-1.66%
Dec 31, 2021	2.76B	161.54M	6.21%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 29, 2026

Data Sources Report a data error